As of 8:10 PM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).
Executive Profile*
Bernard L. Kasten Jr., Ph.D., M.D.Executive Chairman, Chief Executive Officer, President, Interim Chief Financial Officer and Member of Scientific Advisory Board, GeneLink Inc. | |
| Age | Total Calculated Compensation | This person is connected to 40 board members in 7 different organizations across 9 different industries.
See Board Relationships |
| 66 | $98,660
As of Fiscal Year 2012 |
Background*
Dr. Bernard L. Kasten, Jr., Ph.D., M.D. serves as the Chief Executive Officer of GeneLink Inc. and has been its President since 20, 2010 and Interim Chief Financial Officer since 8, 2013. Dr. Kasten serves as Chief Medical Officer of GeneWize Life Sciences, Inc. He is the Founder of Plexus Vaccine Inc. He served as Acting Chief Executive Officer and President of GeneLink Inc. since December 20, 2010. Dr. Kasten served as Secretary of Seracare Life Sciences Inc. From ... 1995 to 2004, Dr. Kasten served at Quest Diagnostics Inc., where he served as Chief Laboratory Officer and Vice President of Medical Affairs of its Subsidiary MedPlus Inc. He served as Vice President of Business Development for Medicine and Science of Quest Diagnostics, Inc. since 1996 and worked until 2004. Dr. Kasten served as Chief Executive Officer of SIGA Technologies Inc. from July 6, 2004 to April 30, 2006. He served as Scientific Advisor of GeneLink Inc. since 1999. His staff appointments have included service in the Division of Laboratory Medicine at The Cleveland Clinic and Associate Director of Pathology and Laboratory Services at the Bethesda Hospital Systems in Cincinnati. He has been the Executive Chairman of GeneLink Inc. since July 2007. Dr. Kasten served as Chairman of Cleveland BioLabs, Inc. from August 30, 2006 to April 2013. He has been Vice Chairman of CytoLogic, Inc. since 2007 and its Director since 2003. He has been an Independent Director of Cleveland Biolabs, Inc. since July 20, 2006. He has been a Lead Independent Director of Enzo Biochem Inc. since March 3, 2011 and as its Director since January 2008. He has been a Director of Cleveland BioLabs, Inc. since July 20, 2006. He serves as Director of Lexi-Comp Inc., GeneLink Inc., Riggs-Heinrich Media Inc., Highway Composites LLC, Monroeville Industrial Molding Inc. and PIPO Inc. He also serves on the Scientific Advisory Board of Structural Bio Informatics Inc. He has been a Member of Scientific Advisory Board of GeneLink Inc. since 1999. He serves as a Member of Scientific Advisory Board of GeneWize Life Sciences, Inc. He served as a Director of Seracare Life Sciences Inc. since September 25, 2001. He served as a Director of Biomat USA, Inc. from March 30, 2001 to September 2001. He served as a Director of SIGA Technologies Inc. from May 23, 2003 to April 30, 2006. He is the author of many professional and scientific articles and is a Principal Author of the "Infectious Disease Handbook" 5th Edition Lexi-Comp Inc., Hudson, OH, 2002. Dr. Kasten is the author of "Infectious Disease Handbook" 1st to 5th Editions from 1994 to 2003 and the "Laboratory Test Handbook" 1st through 4th Editions from 1984 to 1996 published by Lexi-Comp Inc., Hudson, Ohio. Dr. Kasten received the College of American Pathologists President Medal Awarded for Outstanding Service in 1989 and the College of American Pathologists Frank W. Hartman Award, in 1993 for Meritorious Service to the College. His residency served at the University of Miami, Florida and fellowships at the National Institutes of Health Clinical Center and National Cancer Institute, Bethesda, Maryland. Dr. Kasten is a Diplomat of the American Board of Pathology with Certification in Anatomic and Clinical Pathology with sub-specialty certification in Medical Microbiology. Dr. Kasten is a graduate of Miami University (Oxford Ohio), BA Chemistry 1967, and the Ohio State University College of Medicine MD 1971. He received B.S. in Psychology Loyola University, New Orleans.
Corporate Headquarters*
8240 Exchange Drive
Orlando, Florida 32809
United States
Phone: 800-558-4363
Fax: --
Board Members Memberships*
Executive Chairman, Chief Executive Officer, President, Interim Chief Financial Officer and Member of Scientific Advisory Board 2001-Present Director 2001-N/A Former Secretary, Director and Member of Nominating & Governance Committee 2003-2006 Former Chief Executive Officer, Director and Member of Special Committee 2003-Present Vice Chairman and Chief Scientific Officer 2006-Present Independent Director 2008-Present Lead Independent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating/Governance Committee
Education*
Unknown/Other Education College of Medicine, Ohio State University MD 1971 College of Medicine, Ohio State University BA 1967 Miami University BS Loyola University New Orleans
Other Affiliations*
|
Annual Compensation*
| Salary | $15,954 | | Total Annual Compensation | $15,954 |
Stock Options*
| All Other Compensation | $7,768 | | Exercisable Options | 3,606,250 | | Unexercisable Options | 1,927,083 | | Total Number of Options | 5,533,333 |
Total Compensation*
| Total Annual Cash Compensation | $23,722 | | Total Short Term Compensation | $15,954 | | Other Long Term Compensation | $7,768 | | Total Calculated Compensation | $98,660 |
|
*Data is at least as current as the most recent Definitive Proxy.
